Problem statement: Answer the multiple-choice question.
Question: Which compound has a -4.188% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) Cc1nc(SCC(=O)Nc2ccnc3ccccc23)n[nH]1
b) CCOC(=O)c1cc(-c2ccccc2)sc1NC(=O)C(C)Sc1nnnn1C
c) Cc1ccccc1-c1nc(P(=O)(c2ccccc2)c2ccccc2)c(N2CCOCC2)o1
d) COc1cc(-c2nc(-c3cccc(C)c3)no2)cc(OC)c1OC
Answer: a. Cc1nc(SCC(=O)Nc2ccnc3ccccc23)n[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCC(=O)Nc2ccnc3ccccc23)n[nH]1
Cc1nc(SCC(=O)Nc2ccnc3ccccc23)n[nH]1
2-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanyl]-N-quinolin-4-ylacetamide